Atlas Trials

RCT of Different Effects of Nucleot(s)Ide Analogues on the Prognosis of HBV-HCC Patients After Curative Resection

Clinical trial NCT04032860 · UNKNOWN

Trial details

NCT number
NCT04032860
Sponsor
West China Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
HCCHBV Coinfection
Start date
2017-07-01
Primary completion
2022-07-01
Enrollment
104

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.